TROG 12.01 (HPV Oropharynx)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)

Title

Weekly Cetuximab/RT Vs Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

Final Accrual

189

Trial Status

Closed to accrual, 7 June 2018

Trial chairpersons

Prof Danny Rischin and A/Prof June Corry

Trial contact

Ania Matera
Biostatisitics and Clinical Trials
BaCT Department, Peter MacCallum Cancer Centre
305 Grattan street, Melbourne, Vic, 3000
Phone: +61 3 8559 7526
Email: anetta.matera@petermac.org

Further information

TROG trial 12.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 12.01 member page